Company: SUPN
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001356576-25-000071
Chunk: 206

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 206
---
 by the Company are as follows (dollars in thousands):September 30, 2025December 31, 2024(unaudited)Corporate, U.S. government agency and municipal debt securitiesAmortized cost$129,829 $384,481 Gross unrealized gains6 89 Gross unrealized losses(46)(289)Total fair value$129,789 $384,281  As of September 30, 2025, all of the Company's unrestricted available-for-sale marketable securities have contractual maturities of one year or less.

As of September 30, 2025, there was no impairment due to credit loss on any available-for-sale marketable securities. 

6.    Fair Value of Financial Instruments

The fair value of an asset or liability represents the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between unrelated market participants.The Company reports the fair value of assets and liabilities using a three level measurement hierarchy that prioritizes the inputs used to measure fair value. Fair value hierarchy consists of the following three levels: •Level 1—Valuations based on unadjusted quoted prices in active markets that are accessible at measurement date for identical assets. •Level 2—Valuations based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active and model-based valuations in which all significant inputs are observable in the market, either directly or indirectly (e.g., interest rates; yield curves). •Level 3—Valuations using significant inputs that are unobservable in the market and inputs that reflect the Company's own assumptions. These are based on the best information available, including the Company's own data. Financial Assets and Liabilities Recorded at Fair ValueThe Company's financial assets and liabilities that are required to be measured at fair value on a recurring basis are as follows (dollars in thousands):Fair Value Measurements as of September 30, 2025 (unaudited) TotalLevel 1 Level 2Level 3Assets:Cash and cash equivalentsCash$56,614 $56,614 $— $— Money market funds94,757 94,757 — — Marketable securitiesCorporate debt securities109,947 — 109,947 — Municipal debt securities5,712 —5,712 —U.S government agency securities14,130 —14,130